HB 39

86(R) - 2019
House Public Health
Senate Administration
House Public Health
Senate Administration
Health & Human Services

Vote Recommendation

  • Neutral
  • Neutral
  • Neutral
  • Negative
  • Neutral


John Zerwas
Sarah Davis
Geanie Morrison
Senfronia Thompson
Chris Turner


Alma A. Allen
Steve Allison
Rafael Anchia
Trent Ashby
Cecil Bell Jr.
Keith Bell
Diego Bernal
Dwayne Bohac
Rhetta Andrews Bowers
Brad Buckley
Angie Chen Button
Briscoe Cain
Gina Calanni
Terry Canales
Giovanni Capriglione
Travis Clardy
Sheryl Cole
Philip Cortez
Tom Craddick
John Cyrier
Drew Darby
Jay Dean
Joe Deshotel
Jessica Farrar
Dan Flynn
John Frullo
Barbara Gervin-Hawkins
Bobby Guerra
Ryan Guillen
Sam Harless
Cody Harris
Cole Hefner
Abel Herrero
Justin Holland
Donna Howard
Dan Huberty
Jarvis Johnson
Kyle Kacal
Ken King
John Kuempel
Stan Lambert
Brooks Landgraf
Oscar Longoria
Ray Lopez
Eddie Lucio III
Armando Martinez
Will Metcalf
Rick Miller
Ina Minjarez
Joe Moody
Tom Oliverson
Evelina Ortega
Leo Pacheco
Chris Paddie
Tan Parker
Mary Ann Perez
Four Price
John Raney
Richard Raymond
Eddie Rodriguez
Ramon Romero Jr.
Toni Rose
J.D. Sheffield
Carl Sherman
Hugh Shine
Reggie Smith
Lynn Stucky
Ed Thompson
Gary VanDeaver
Hubert Vo
James White
John Wray
Gene Wu
Erin Zwiener

Bill Caption

Relating to the repeal of certain time limitations on the award of grants by the Cancer Prevention and Research Institute of Texas Oversight Committee.

Fiscal Notes

According to the Legislative Budget Board, no fiscal impact to the state is anticipated. 

Bill Analysis

Current statute prohibits the Cancer Prevention and Research Institute of Texas Oversight Committee (CPRIT) after August 31, 2022. HB 39 would repeal that expiration date and effectively allow CPRIT to continue granting public dollars to institutions of higher education for cancer research in perpetuity. 

Vote Recommendation Notes

Texas Action opposes HB 39 on the grounds that it violates the principle of limited government. When CPRIT was first authorized, it was designed to be a temporary program. Rather than continue its functions as a public entity CPRIT should be allowed to sunset as scheduled. This organization is long on spending, short on results, and performs a function that is better left to faith-based and private philanthropic organizations.

Between the federal government and the vast amount of nonprofit organizations in Texas and throughout the United States, funding for cancer research is at an all-time high. A redundancy in this area at the expense of the taxpayer, many of whom voluntarily fund cancer research themselves, is inefficient and unnecessary. Instead the state should encourage the growth of more nonprofit cancer funding by reducing the overall tax burden upon our economy. We do not oppose the mission or goals of CPRIT, but rather prefer for the organization to be entirely funded by private dollars and operate entirely apart from state involvement.